Last edition
News about
ICMR to present fully indigenous diagnostic platform for COVID-19
The Indian Council of Medical Research (ICMR) has validated a fully indigenous diagnostic platform for COVID-19 diagnosis.
Bayer has submitted an application for marketing authorization for its precision oncology treatment larotrectinib to the Ministry of Health, Labor and Welfare (MHLW) in Japan. Larotrectinib is an oral TRK inhibitor that has been developed specifically to treat adults and children
GSK Pharma to discontinue manufacture & supply of Zinetac tablets in India
GlaxoSmithKline Pharmaceuticals announced that the company has decided to discontinue the manufacture and supply of Zinetac tablets, used to treat and prevent heartburn
FDA Provides Promised Transparency for Antibody Tests
Today, the U.S. Food and Drug Administration posted a list of antibody tests that are being removed from the notification list of tests being offered under the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency
Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use
Roche today announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche's nanopore sequencer. The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX).
Independent external council to advise Bayer's Board of Management on consistent implementation
An independent Sustainability Council will advise the Board of Management of Bayer AG and other functions within the company in all sustainability matters. The Council is a major part of the greater commitment to sustainability that Bayer announced last year
Covid-19: Pune-based drug firm to export favipiravir to 18 countries
Pune-based pharmaceutical marketing company Brinton Pharmaceuticals is gearing up to export anti-viral drug favipiravir to 18 countries and awaiting approval from the Indian drug controller to launch the drug in India
Cipla files ANDA for generic version of GSK's Advair Diskus to US FDA
Cipla Limited announced its submission of an Abbreviated New Drug Application (ANDA) for fluticasone propionate and salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg) to the United States Food and Drug Administration (FDA)
Dr Lal PathLabs Q4 net profit dips 31% to Rs. 32.6 crore
Dr Lal PathLabs Limited, a leading diagnostic and related healthcare service provider posted 31% dip in net profit at Rs. 32.6 crore for the fourth quarter ended March 31, 2020 as compared to Rs. 47.4 crore in Q4 last year
The department of Ayurveda, Yoga, Unani, Shiddha and Homoeopathy (Ayush) in collaboration with Council of Scientific and Industrial Research (CSIR) is working on developing four formulations of traditional medicine to treat the novel coronavirus infections and accordingly clinical trials are also being planned within next one week
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy